A detailed history of Greylin Investment Mangement Inc transactions in Organon & Co. stock. As of the latest transaction made, Greylin Investment Mangement Inc holds 809,119 shares of OGN stock, worth $12 Million. This represents 2.96% of its overall portfolio holdings.

Number of Shares
809,119
Previous 793,851 1.92%
Holding current value
$12 Million
Previous $14.9 Million 12.22%
% of portfolio
2.96%
Previous 2.53%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 19, 2024

BUY
$17.45 - $21.96 $266,426 - $335,285
15,268 Added 1.92%
809,119 $16.7 Million
Q1 2024

Apr 24, 2024

SELL
$13.78 - $18.8 $127,409 - $173,824
-9,246 Reduced 1.15%
793,851 $14.9 Million
Q4 2023

Jan 25, 2024

BUY
$10.95 - $17.32 $478,580 - $756,987
43,706 Added 5.76%
803,097 $11.6 Million
Q3 2023

Oct 10, 2023

BUY
$16.59 - $23.77 $945,547 - $1.35 Million
56,995 Added 8.11%
759,391 $13.2 Million
Q2 2023

Jul 10, 2023

BUY
$19.27 - $24.63 $2.42 Million - $3.1 Million
125,823 Added 21.82%
702,396 $14.6 Million
Q1 2023

Apr 07, 2023

BUY
$21.42 - $32.08 $186,868 - $279,865
8,724 Added 1.54%
576,573 $13.6 Million
Q4 2022

Jan 25, 2023

BUY
$23.31 - $28.61 $4.2 Million - $5.16 Million
180,329 Added 46.53%
567,849 $0
Q3 2022

Oct 13, 2022

BUY
$23.4 - $34.25 $1.65 Million - $2.41 Million
70,396 Added 22.2%
387,520 $9.07 Million
Q2 2022

Jul 11, 2022

BUY
$31.66 - $38.9 $10 Million - $12.3 Million
317,124 New
317,124 $10.7 Million
Q1 2022

May 20, 2022

SELL
$30.45 - $39.36 $9.99 Million - $12.9 Million
-328,167 Closed
0 $0
Q4 2021

Feb 15, 2022

BUY
$28.67 - $37.13 $19,409 - $25,137
677 Added 0.21%
328,167 $9.99 Million
Q3 2021

Oct 13, 2021

BUY
$28.63 - $35.64 $2.56 Million - $3.18 Million
89,265 Added 37.47%
327,490 $10.7 Million
Q2 2021

Jul 14, 2021

BUY
$28.45 - $38.0 $6.78 Million - $9.05 Million
238,225 New
238,225 $7.21 Million

Others Institutions Holding OGN

About Organon & Co.


  • Ticker OGN
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 254,330,000
  • Market Cap $3.76B
  • Description
  • Organon & Co., a health care company, develops and delivers health solutions through a portfolio of prescription therapies in the United States and internationally. Its women's health portfolio comprises contraception and fertility brands, such as Nexplanon/Implanon, a long-acting reversible contraceptive. The company's biosimilars portfolio...
More about OGN
Track This Portfolio

Track Greylin Investment Mangement Inc Portfolio

Follow Greylin Investment Mangement Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Greylin Investment Mangement Inc, based on Form 13F filings with the SEC.

News

Stay updated on Greylin Investment Mangement Inc with notifications on news.